Debra Borchardt
Contributor since: 2015
Green Thumb Industries Is Growing Under The Cannabis Radar
High Times Is Running Out Of Time
Kush Bottles' Main Challenge Is Managing Growth - Debra Borchardt's Idea Of The Month
Kush Bottles Is Locking Up The California Cannabis Market
GrowGeneration Has Room To Run - Debra Borchardt's Idea Of The Month
GrowGeneration Is Building Its Base For Growth
McDonald's Munchies - Debra Borchardt's Idea Of The Month
JuJu Royal's Future Is Looking Brighter
MassRoots New President Defends Price Paid For CannaRegs
Medreleaf Corp. Expanding And Increasing Sales - Debra Borchardt's Idea Of The Month
Zynerba Strikes Out In Phase 2 Study For Epilepsy Drug
Northsight Capital Makes Cannabis Stocks Look Bad
Zynerba Pharmaceuticals: Scalable With Less Risk - Debra Borchardt's Idea Of The Month
Therapix Biosciences Gets A Buy Rating From Laidlaw Analyst
CURE Pharmaceutical Initiates Cancer Cannabis Study
MassRoots Earnings Show Company Is Putting Up A Good Fight
GrowGeneration Buys Hydroponic Store In Seattle
Marketplace Roundtable: Marijuana Money
GW Pharmaceuticals' Earnings Biding Time Until Epidiolex Is On The Market
Insys Therapeutics Sees Subsys Scrips Dive With No Replacement
GW Pharmaceuticals Beats On Earnings, Light On Revenue
Insys Therapeutics' Revenue Jumps, But Legal Case Looms
Blue Line Protection Group Worth The Risk
Insys Therapeutics Delivers Eighth Straight Profitable Quarter
Six Robotics Stocks For 2015
Robotics Crowd Picks Drones As Top Investment Idea
Insys Therapeutics Shakes Off Script Scandal